Table 6 Relative size of incentive payments to revenue
| Scheme, study | Country | Payment/Revenue (%) |
|---|---|---|
| Spontaneous breathing trials (SBTs), [8] | US | 7.5 |
| CAPI-ROSP, [9,10,11] | France | 4–7 |
| Rwanda P4P, [12] | Rwanda | 22 |
| P4P for Maternal care, [13,14,15] | Tanzania | 10–25 |
| P4P for Antibiotics, [16] | Sweden | 0.05–1.2 |
| Quality and Outcomes Framework, [17] | UK | 25 |
| Afghanistan P4P, [18] | Afghanistan | 6–28 |